Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Gastric Insufflation

Tundra lists 4 Gastric Insufflation clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07555080

Comparison of Gastric Volume Changes After Ventilation With Endotraceal Tube, First Generation Supraglottic Airway and Second Generation Supraglottic Airway in Pediatric Patients

This study aims to compare the gastric volumes of pediatric patients undergoing positive pressure ventilation with different airway management techniques. Gastric ultrasound is a non-invasive bedside tool with high sensitivity and specificity for determining the nature and amount of gastric content. In pediatric cases, maintaining a gastric volume below 1.25 ml/kg is associated with a lower risk of perioperative aspiration. Although supraglottic airway devices (SADs) are commonly used as alternatives to endotracheal tubes, concerns regarding the potential for gastric insufflation and subsequent aspiration persist. Second-generation SADs were specifically designed with gastric drainage channels to mitigate the risk of regurgitation compared to first-generation devices. The primary objective of this study is to determine whether there is difference in gastric volumes, as measured by ultrasound, among three groups of pediatric patients: those managed with endotracheal tubes, first-generation SADs, and second-generation SADs. By comparing these measurements post-ventilation, the investigators aim to evaluate the impact of the airway device choice on gastric volume under clinical conditions.

Gender: All

Ages: 1 Year - 10 Years

Updated: 2026-04-28

Gastric Ultrasonography
Supraglottic Airways
Supraglottic Airway Use in Children
+3
NOT YET RECRUITING

NCT07480031

Determination of the Optimal Inspiratory Pressure to Decrease Incidence of Gastric Insufflation With Adequate Ventilation During Facemask Ventilation in Morbidly Obese Patients

The goal of this randomized clinical trial is to optimize the inspiratory pressure during facemask ventilation (FMV) in morbidly obese patients (BMI ≥40 kg/m²), to ensure adequate ventilation while minimizing the risk of gastric insufflation by real-time ultrasound guidance

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-03-18

Gastric Insufflation
RECRUITING

NCT07451470

Comparison of Gastric Insufflation Volume Between LarySeal Pro and Ambu AuraGain Using Ultrasonography In Pediatric Patients Undergoing General Anesthesia With Controlled Ventilation.

Gastric air insufflation during insertion of a laryngeal mask airway (LMA) is a known phenomenon and can have important clinical implications, especially in relation to: During positive pressure ventilation or improper insertion technique, air can be forced into the esophagus and stomach or LMAs do not fully seal the esophagus, so high ventilation pressures or incorrect placement may lead to gastric insufflation. Which may lead to Increased risk of regurgitation and aspiration, especially if the gastric contents reach the upper esophagus, Abdominal distension, which can reduce ventilation efficiency, nausea, vomiting, or delayed gastric emptying postoperatively which detected by Epigastric auscultation may reveal gurgling sounds during ventilation, Gastric ultrasound can visualize the extent of gastric insufflation and Capnography sometimes shows altered patterns if regurgitation begins . This complication prevented by: * Use low-pressure, controlled ventilation (\<20 cmH₂O). * Ensure proper size and positioning of the LMA. * Use second-generation LMAs (like LarySealPro or Ambu AuraGain LMA) that have gastric drainage ports to relieve air. Consider gastric ultrasound preoperatively to assess risk . (1) Several studies have assessed the performance of Ambu AuraGain and LarySeal Pro individually or in comparison with other supraglottic airway devices. Ambu AuraGain, a second-generation device with a gastric drainage channel, has demonstrated high oropharyngeal leak pressures and ease of insertion, making it suitable for positive pressure ventilation. LarySeal Pro has also shown favorable results in terms of low airway resistance and effective sealing in adults. However, direct comparisons between these two devices are limited, especially regarding gastric insufflation volume measured by ultrasonography, which offers objective and quantitative assessment. Although some adult studies have evaluated AuraGain against devices like ProSeal or i-gel, there is a notable lack of pediatric studies directly comparing AuraGain and LarySeal Pro using gastric ultrasound techniques.(2) To date, no published randomized controlled trials have directly compared gastric insufflation volumes between Ambu AuraGain and LarySeal Pro using ultrasonography in pediatric patients under general anesthesia. This represents a critical gap in the literature, given the increased risk of aspiration in children and the growing use of ultrasound to evaluate perioperative gastric content. Compared to Endotracheal intubation , SADs offer reported advantages such as simplicity in insertion, elimination of neuromuscular blocking agents, enhancement of spontaneous respiration, and avoidance of translaryngeal positioning accompanied by cardiovascular effects and close vocal cord contact. reduced rate of laryngospasm and a lower incidence of postoperative hoarse voice, coughing and sore throat. (3) Despite this, the use of these device may be associated with various complications as regurgitation and aspiration of gastric contents, compression of vascular structures, trauma, and nerve injury.(4). The LMA can be a useful airway device in pediatric patients as well as adults, despite clear differences between the anatomy of the pediatric and adult airway. Sizes I, 2, and 2 1/2 are available for use in infants and children. In general, children require greater anesthetic depth prior to placement . The LMA can be placed successfully in children after either an inhalational or intravenous induction of anesthesia. (5) Ambu AuraGain and LarySeal Pro are designed with a cuff modified to improve the seal around the glottis and a drainage tube to provide a bypass channel for regurgitated gastric contents, prevent gastric insufflation, and allow the passage of a gastric tube. These features are designed to improve the safety of the mask and broaden its scope, especially when used with positive pressure ventilation.(6) Aim of the work The aim of the study is to compare the gastric insufflation volume between the LarySeal Pro Laryngeal Mask and Ambu AuraGain Laryngeal Mask in pediatric patients undergoing general anesthesia with controlled ventilation. Objectives: To assess and compare gastric insufflation volume between LarySeal Pro laryngeal mask and Ambu AuraGain laryngeal mask in pediatric patients using pelviabdominal ultrasound undergoing general anesthesia. Hypothesis We hypothesize that LarySeal Pro laryngeal mask produce gastric insufflation volume less than Ambu AuraGain laryngeal mask in pediatric patients undergoing general anesthesia.

Gender: All

Ages: 6 Years - 10 Years

Updated: 2026-03-05

1 state

Gastric Insufflation
RECRUITING

NCT06853756

Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia

Our study aimed to compare the gastric insufflation volume between Ambu AuraGain and i-gel and its relationship with the oropharyngeal sealing pressure and the incidence of postoperative complications in generally anesthetized controlled-ventilated pediatric patients undergoing elective orthopedic operations.

Gender: All

Ages: 2 Years - 12 Years

Updated: 2025-03-03

1 state

Gastric Insufflation
I-gel
Ambu AuraGain
+3